Exploration of IMDC model in patients with metastatic renal cell carcinoma using targeted agents: a meta-analysis

International braz j urol ◽

10.1590/s1677-5538.ibju.2019.0423 ◽

2020 ◽

Vol 46 (3) ◽

pp. 328-340

Author(s):

Guiya Jiang ◽

Shuqiu Chen ◽

Ming Chen

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Targeted Agents

Download Full-text

The Effectiveness of Sorafenib over Other Targeted Agents in the Second-Line Treatment of Metastatic Renal Cell Carcinoma: a Meta-Analysis

Pathology & Oncology Research ◽

10.1007/s12253-018-0516-3 ◽

2018 ◽

Vol 25 (4) ◽

pp. 1497-1503 ◽

Author(s):

Hou-Feng Huang ◽

Xin-Rong Fan ◽

Zhi-Gang Ji

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Line Treatment ◽

Second Line ◽

Targeted Agents

Download Full-text

Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2016.01.014 ◽

2016 ◽

Vol 99 ◽

pp. 324-331 ◽

Author(s):

Roberto Iacovelli ◽

Elena Verri ◽

Maria Cossu Rocca ◽

Gaetano Aurilio ◽

Daniela Cullurà ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Targeted Agents

Download Full-text

Indirect comparisons of efficacy and safety between seven newer targeted agents for metastatic renal cell carcinoma: A network meta-analysis of randomised clinical trials

Molecular and Clinical Oncology ◽

10.3892/mco.2014.323 ◽

2014 ◽

Vol 2 (5) ◽

pp. 858-864 ◽

Author(s):

HENRY W.C. LEUNG ◽

AGNES L.F. CHAN ◽

SHUN-JEN LIN

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Trials ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Randomised Clinical Trials ◽

Targeted Agents ◽

Efficacy And Safety ◽

Indirect Comparisons

Download Full-text

P040 Antiangiogenic targeted agents improve overall survival in metastatic Renal Cell Carcinoma (mRCC). A meta-analysis of published trials

European Urology Supplements ◽

10.1016/s1569-9056(13)62366-0 ◽

2013 ◽

Vol 12 (6) ◽

pp. 144

Author(s):

R. Iacovelli ◽

E. Verzoni ◽

A. Palazzo ◽

P. Grassi ◽

I. Testa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Targeted Agents

Download Full-text

A meta-analysis of efficacy and safety of sorafenib versus other targeted agents for metastatic renal cell carcinoma

Medicine ◽

10.1097/md.0000000000013779 ◽

2019 ◽

Vol 98 (1) ◽

pp. e13779 ◽

Author(s):

Hai-Tao Wang ◽

Ming Xia

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Targeted Agents ◽

Efficacy And Safety

Download Full-text

Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2021.102242 ◽

2021 ◽

pp. 102242

Author(s):

Keiichiro Mori ◽

Benjamin Pradere ◽

Fahad Quhal ◽

Satoshi Katayama ◽

Hadi Mostafaei ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Programmed Cell Death ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Programmed Cell Death 1

Download Full-text

A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma

European Urology ◽

10.1016/j.eururo.2021.03.016 ◽

2021 ◽

Author(s):

Irbaz Bin Riaz ◽

Huan He ◽

Alexander J. Ryu ◽

Rabbia Siddiqi ◽

Syed Arsalan Ahmed Naqvi ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials

European Journal of Cancer ◽

10.1016/j.ejca.2021.06.015 ◽

2021 ◽

Vol 154 ◽

pp. 120-127

Author(s):

Francesco Massari ◽

Alessandro Rizzo ◽

Veronica Mollica ◽

Matteo Rosellini ◽

Andrea Marchetti ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Trials ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Meta Analysis ◽

Randomised Clinical Trials

Download Full-text

MP69-02 SURVIVAL COMPARISON ANALYSIS OF TWO HISTORICAL COHORTS OF METASTATIC RENAL CELL CARCINOMA PATIENTS (CYTOKINE THERAPY VS. TARGETED AGENTS) - A EUROPEAN SINGLE-CENTER EXPERIENCE OVER 26 YEARS

The Journal of Urology ◽

10.1016/j.juro.2015.02.2506 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Georg C. Hutterer ◽

Silvia Golbeck ◽

Edvin Mrsic ◽

Daniel Krieger ◽

Angelika Bezan ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Cytokine Therapy ◽

Targeted Agents ◽

Single Center ◽

Comparison Analysis ◽

Single Center Experience

Download Full-text

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.10.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. 280-286 ◽

Author(s):

Andreas Nearchou ◽

Antonis Valachis ◽

Pehr Lind ◽

Olof Akre ◽

Per Sandström

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Predictive Marker

Download Full-text